SUV39H1 and central nervous system cancer: In summary, our findings demonstrated that the interaction of MeCP2 with SUV39H1, and deliver H3K9 to the promoter of miR-200c, resulting in the transcriptional repression of the miR-200c, and then activates EMT in glioma (Fig. 10).